299 related articles for article (PubMed ID: 33045848)
1. Emerging systemic therapies for atopic dermatitis: biologics.
Nusbaum KB; Nguyen CM; Fleischer AB
J Dermatolog Treat; 2022 May; 33(3):1269-1273. PubMed ID: 33045848
[TBL] [Abstract][Full Text] [Related]
2. Are Biologics Efficacious in Atopic Dermatitis? A Systematic Review and Meta-Analysis.
Snast I; Reiter O; Hodak E; Friedland R; Mimouni D; Leshem YA
Am J Clin Dermatol; 2018 Apr; 19(2):145-165. PubMed ID: 29098604
[TBL] [Abstract][Full Text] [Related]
3. Biologic Versus Small Molecule Therapy for Treating Moderate to Severe Atopic Dermatitis: Clinical Considerations.
Butala S; Castelo-Soccio L; Seshadri R; Simpson EL; O'Shea JJ; Bieber T; Paller AS
J Allergy Clin Immunol Pract; 2023 May; 11(5):1361-1373. PubMed ID: 36948491
[TBL] [Abstract][Full Text] [Related]
4. Current and emerging biologics for the treatment of pediatric atopic dermatitis.
Ghamrawi R; Bell KA; Balogh EA; Strowd LC; Feldman SR
Expert Opin Biol Ther; 2020 Dec; 20(12):1435-1445. PubMed ID: 33078990
[TBL] [Abstract][Full Text] [Related]
5. Biologics for Treatment of Atopic Dermatitis: Current Status and Future Prospect.
Ratchataswan T; Banzon TM; Thyssen JP; Weidinger S; Guttman-Yassky E; Phipatanakul W
J Allergy Clin Immunol Pract; 2021 Mar; 9(3):1053-1065. PubMed ID: 33685604
[TBL] [Abstract][Full Text] [Related]
6. Biological Therapies for Atopic Dermatitis: A Systematic Review.
Zhou S; Qi F; Gong Y; Zhang J; Zhu B
Dermatology; 2021; 237(4):542-552. PubMed ID: 33735876
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of biologics and oral small molecules for atopic dermatitis: a systematic review and meta-analysis.
Nusbaum KB; Fleischer S; Fleischer AB
J Dermatolog Treat; 2022 Aug; 33(5):2534-2544. PubMed ID: 34620047
[TBL] [Abstract][Full Text] [Related]
8. Relative efficacy of systemic treatments for atopic dermatitis.
Seger EW; Wechter T; Strowd L; Feldman SR
J Am Acad Dermatol; 2019 Feb; 80(2):411-416.e4. PubMed ID: 30296535
[TBL] [Abstract][Full Text] [Related]
9. Emerging systemic therapies for atopic dermatitis: oral small molecules and targeted topical agents.
Nusbaum KB; Nguyen CM; Fleischer AB
J Dermatolog Treat; 2022 May; 33(3):1274-1278. PubMed ID: 33143506
[TBL] [Abstract][Full Text] [Related]
10. Biologics for Atopic Dermatitis.
Boguniewicz M
Immunol Allergy Clin North Am; 2020 Nov; 40(4):593-607. PubMed ID: 33012322
[TBL] [Abstract][Full Text] [Related]
11. Current and Future Monoclonal Antibodies in the Treatment of Atopic Dermatitis.
Chun PIF; Lehman H
Clin Rev Allergy Immunol; 2020 Oct; 59(2):208-219. PubMed ID: 32617839
[TBL] [Abstract][Full Text] [Related]
12. Biological medication in atopic dermatitis.
Fölster-Holst R; Torrelo A; Das K; Murrell DF; Patil A; Rahmat Pour Rokni G; Grabbe S; Staubach P; Sohn A; Goldust M
Expert Opin Biol Ther; 2022 May; 22(5):643-649. PubMed ID: 34991429
[TBL] [Abstract][Full Text] [Related]
13. [BIOLOGICS IN THE TREATMENT OF ATOPIC DERMATITIS -CURRENT STATUS AND FUTURE PROSPECTS].
Nakahara T
Arerugi; 2023; 72(10):1211-1214. PubMed ID: 38092396
[No Abstract] [Full Text] [Related]
14. Trial of Nemolizumab and Topical Agents for Atopic Dermatitis with Pruritus.
Kabashima K; Matsumura T; Komazaki H; Kawashima M;
N Engl J Med; 2020 Jul; 383(2):141-150. PubMed ID: 32640132
[TBL] [Abstract][Full Text] [Related]
15. Nemolizumab in patients with moderate-to-severe atopic dermatitis: Randomized, phase II, long-term extension study.
Kabashima K; Furue M; Hanifin JM; Pulka G; Wollenberg A; Galus R; Etoh T; Mihara R; Nakano M; Ruzicka T
J Allergy Clin Immunol; 2018 Oct; 142(4):1121-1130.e7. PubMed ID: 29753033
[TBL] [Abstract][Full Text] [Related]
16. Biologics and Small Molecule Agents in Allergic and Immunologic Skin Diseases.
Kaufman BP; Alexis AF
Curr Allergy Asthma Rep; 2018 Aug; 18(10):55. PubMed ID: 30171358
[TBL] [Abstract][Full Text] [Related]
17. Dupilumab for treatment of atopic dermatitis.
Seegräber M; Srour J; Walter A; Knop M; Wollenberg A
Expert Rev Clin Pharmacol; 2018 May; 11(5):467-474. PubMed ID: 29557246
[TBL] [Abstract][Full Text] [Related]
18. Anti-Interleukin-31 Receptor A Antibody for Atopic Dermatitis.
Ruzicka T; Hanifin JM; Furue M; Pulka G; Mlynarczyk I; Wollenberg A; Galus R; Etoh T; Mihara R; Yoshida H; Stewart J; Kabashima K;
N Engl J Med; 2017 Mar; 376(9):826-835. PubMed ID: 28249150
[TBL] [Abstract][Full Text] [Related]
19. Review and analysis of biologic therapies currently in phase II and phase III clinical trials for atopic dermatitis.
Uppal SK; Kearns DG; Chat VS; Han G; Wu JJ
J Dermatolog Treat; 2022 Mar; 33(2):626-636. PubMed ID: 32507066
[TBL] [Abstract][Full Text] [Related]
20. Dupilumab: A review of its use in the treatment of atopic dermatitis.
Gooderham MJ; Hong HC; Eshtiaghi P; Papp KA
J Am Acad Dermatol; 2018 Mar; 78(3 Suppl 1):S28-S36. PubMed ID: 29471919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
